Products

OncoAI Suite (BrainTumor AI)
Carina AI
Oncology AI
OncoAI Suite is an AI-native oncology imaging suite for cancer detection, segmentation, measurement, and longitudinal tracking across CT, MRI, and PET/CT. The BrainTumor AI module is currently in clinical use, providing volumetric tracking for glioma, brain metastasis, and vestibular schwannoma.

See all 1 product →

About Carina AI

Carina AI is an innovative healthcare artificial intelligence company focused on enhancing clinical workflows and improving patient outcomes through advanced AI solutions. Their platform is designed to integrate seamlessly into existing healthcare systems, providing physicians with tools that streamline administrative tasks, optimize diagnostic processes, and personalize treatment plans. By leveraging machine learning and natural language processing, Carina AI aims to reduce physician burnout by automating repetitive tasks, allowing clinicians to dedicate more time to direct patient care.

The company’s technology is particularly relevant for physicians seeking to improve efficiency and accuracy in their practice. Carina AI’s solutions can assist in areas such as medical imaging analysis, predictive analytics for disease progression, and intelligent documentation support. Their goal is to empower healthcare providers with actionable insights derived from complex medical data, ultimately leading to more informed decision-making and a higher quality of care for patients. They emphasize data security and compliance with healthcare regulations, ensuring that patient information is handled with the utmost privacy and integrity.

Focus Areas

Medical imaging AI clinical research data curation radiation oncology auto-contouring dose verification de-identification multimodal data processing

Business Intelligence

Key InvestorsNIH SBIR awards
PartnershipsMayo Clinic, Johns Hopkins, Penn, Duke, UVA, Emory, Colorado, Brown, UTSW, Kentucky (academic medical centers)
TechnologyOn-premise, AI-Native Multimodal Data Curation Platform (CuratAI), local LLM for structured data extraction
FDA Clearances2 cleared products (estimated)

What Physicians Need to Know

Medical Imaging AI & Radiation Oncology
Carina AI offers FDA 510(k)-cleared products like INTContour for AI-native auto-contouring (120+ OARs across CT, MRI, PET/CT) and INTDose for independent Monte Carlo 3D secondary dose verification. They also have NIH-supported research tools like OncoAI Suite for oncology imaging (detection, segmentation, tracking of LymphNode, BrainTumor, LungNodule across CT, MRI, PET/CT) and QuantBrain for brain quantification. Their auto-contouring can be customized by clinics to train on their own data.
Clinical Research Data Curation
CuratAI is Carina AI's on-premise, AI-native multimodal data curation platform for clinical research. It handles multi-source retrieval from PACS, EHR, and pathology systems, ingests unstructured data into structured formats using local LLMs, and performs comprehensive de-identification across five PHI vectors (headers, dates, burned-in pixel text, facial features, clinical reports). It also features AI-assisted annotation and a plugin slot for custom AI models.
De-identification & Privacy
Carina AI specializes in pixel-level de-identification, including mask-based defacing that preserves intracranial anatomy while removing facial features, and semantic text de-identification using on-premise LLMs to strip PHI from notes and reports. Their systems are designed for on-premise execution, ensuring patient data remains within the institutional firewall and no PHI leaves the institution.
Multimodal Data Processing
Their CuratAI platform supports multimodal data, including DICOM, NIfTI, WSI, PDF, and clinical notes, through a single pipeline. It can pull data from various sources like PACS, EHR, pathology systems, REDCap, Excel, or CSV exports.
Physician Tip

For physicians, Carina AI's solutions offer enhanced efficiency and accuracy in radiation oncology treatment planning through FDA-cleared auto-contouring (INTContour) and independent dose verification (INTDose). The ability to train custom AI models on local institutional data with INTContour means the AI can adapt to specific clinical protocols, potentially leading to more accurate contours than generic vendor models. For researchers, CuratAI streamlines the often time-consuming process of data curation and de-identification, allowing for faster preparation of research-ready cohorts while maintaining strict privacy standards. The on-premise architecture ensures data security and compliance, a critical factor for sensitive patient information. The AI-assisted annotation can significantly reduce the manual effort in research pipelines. Additionally, the OncoAI Suite and QuantBrain offer advanced AI tools for cancer imaging and brain quantification in research settings, with some components already in clinical use or on the FDA pathway.

Carina AI's INTContour integrates with Treatment Planning Systems (TPS) like Varian Eclipse and supports automated DICOM workflows. Their CuratAI platform connects to PACS, EHR, and pathology systems for multi-source data retrieval and allows for cross-institution sharing of de-identified projects. The platform is designed to run entirely within an institution's network, including its local LLM, without cloud dependencies for PHI processing.

Products by Carina AI

1 product in the directory

OncoAI Suite (BrainTumor AI)
Carina AI
Oncology AI
OncoAI Suite is an AI-native oncology imaging suite for cancer detection, segmentation, measurement, and longitudinal tracking across CT, MRI, and PET/CT. The BrainTumor AI module is currently in clinical use, providing volumetric tracking for glioma, brain metastasis, and vestibular schwannoma.

Reviews & Opinions

No web reviews on file yet for Carina AI. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Carina AI.

Loading videos...

Videos load interactively. If none appear, search YouTube for Carina AI →

View all on YouTube

Press & Coverage

Carina AI
Carina AI at SIIM 2026 u2014 Startup Kiosk 3
Carina AI will be exhibiting at SIIM 2026 from June 10-12, 2026, showcasing live demos of their CuratAI platform and offering opportunities to meet their clinical team. They will be located at Startup Kiosk 3.
2026-06
Carina AI
RSNA 2025 u2014 Booth 4077
Carina AI exhibited at RSNA 2025 in Chicago from November 30 to December 4, 2025, at Booth 4077 in South Hall, Level 3.
2025-11
Frontiers
Evaluating the impact of different deface algorithms on deep learning segmentation software performance
This study, published in Frontiers, evaluates the impact of defacing algorithms on AI-driven organ segmentation in head-and-neck CT images, utilizing Carina AI's DeIdentifier software and INTContour for segmentation.
2025-10
PMC (Journal of Medical Imaging and Radiation Sciences)
Impact of Artificial Intelligence-Based Autosegmentation of Organs at Risk in Low- and Middle-Income Countries
This publication details a study on the impact of AI-based autosegmentation of organs at risk in low- and middle-income countries, employing Carina AI's INTContour platform.
2024-10
Capital Riesgo
Carina IA cierra ronda de financiaciu00f3n de 500.000u20ac y evoluciona hacia Carina AI Studio
Carina IA (Carina AI) has closed a u20ac500,000 funding round and is evolving into Carina AI Studio.
2025-03
Nature Communications
Towards fair decentralized benchmarking of healthcare AI algorithms with the Federated Tumor Segmentation (FeTS) challenge
This peer-reviewed paper from the Carina AI team, published in Nature Communications, discusses fair decentralized benchmarking of healthcare AI algorithms through the Federated Tumor Segmentation (FeTS) challenge.
2025
Carina AI
Carina AI: FDA 510(k) Clearances for INTContour and INTDose
Carina AI received FDA 510(k) clearances in 2022 for two of its products, INTContour (K212274) for AI auto-contouring in radiation oncology and INTDose (K213137) for Monte Carlo 3-D secondary dose verification.
2022
YouTube (CONNECTpreneur)
Carina AI - Virtual Rocket Pitch presentation at CONNECTpreneur
Xue Feng, CEO of Carina AI, presented a virtual rocket pitch at CONNECTpreneur on October 28, 2021, discussing the company's AI technologies for medical image analysis and its goal of improving clinical practices.
2021-11

Frequently Asked Questions

Carina AI offers several key products, including INTContour, an FDA-cleared AI auto-contouring platform for radiation oncology that supports over 120 organs-at-risk (OARs) across various imaging modalities. They also provide INTDose, an FDA-cleared independent Monte Carlo 3D secondary dose verification platform. For research, Carina AI has the OncoAI Suite for tumor detection and tracking, and QuantBrain for ventricle quantification.
Carina AI prioritizes data privacy and compliance through its on-premise architecture, ensuring no protected health information (PHI) leaves the institution's network. Their CuratAI platform offers pixel-level de-identification, including removing facial geometry while preserving intracranial anatomy, and semantic text de-identification from clinical notes and reports using a local Large Language Model (LLM). This approach aligns with HIPAA and IRB requirements, providing audit trails and keeping re-identification linking files within the institutional firewall.
Carina AI's INTContour provides FDA 510(k)-cleared AI auto-contouring with pre-loaded models for over 120 OARs. A key feature is the ability for institutions to train custom segmentation models on their own data, which has been shown to outperform vendor baselines on specific institutional protocols. For dose verification, INTDose offers independent Monte Carlo 3D secondary dose verification.
Yes, Carina AI's platforms are designed for integration. INTContour offers Eclipse TPS integration and supports automated DICOM workflows. CuratAI, their data curation platform, can pull data from PACS, EHR, and pathology systems, and ingest unstructured data into structured formats using a local LLM.
Carina AI provides technical consulting for optimizing AI tool development, including algorithm optimization, performance evaluation, and integration support. They also offer comprehensive support for FDA regulatory compliance, including 510(k) submission preparation. Carina AI partners with research groups, academic medical centers, and medical device companies, offering services like data curation, annotation, custom AI development, and regulatory pathway support.
Carina AI spun out of research labs at the University of Virginia and the University of Kentucky, founded by clinician-engineers. Their research has been supported by NIH SBIR awards, and they have multiple granted US patents and over 40 peer-reviewed publications. Carina Medical, founded in 2019, has raised funding over three rounds, including a grant in September 2022.
Carina AI's CuratAI platform is an on-premise, AI-native multimodal data curation platform for clinical research. It can retrieve data from various sources like PACS, EHR, and pathology systems, and process diverse modalities including DICOM, NIfTI, WSI, and PDFs. The platform also uses local LLMs to extract structured fields from unstructured clinical notes and reports, all while maintaining data privacy within the institutional firewall.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.